Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.855
Peer-review started: December 8, 2023
First decision: December 27, 2023
Revised: January 4, 2024
Accepted: January 29, 2024
Article in press: January 29, 2024
Published online: February 28, 2024
Processing time: 80 Days and 9.9 Hours
Reflux esophagitis has an increasing prevalence and complex and diverse symptoms. Identifying its risk factors is crucial to understanding the etiology, prevention, and management of the disease.
The occurrence of reflux esophagitis may be associated with food reactions, Helicobacter pylori (H. pylori) infection, and metabolic syndromes.
To investigate the risk factors for reflux esophagitis and analyze the effects of IgG-mediated food intolerance, H. pylori infection, and metabolic syndrome on reflux esophagitis.
This retrospective study analyzed endoscopic images of outpatients attending the Second Medical Center of PLA General Hospital between 2017 and 2021, classified them into non-RE and RE groups, and further explored the differences in IgG-mediated food intolerance, H. pylori infection, and metabolic syndrome of the different groups.
In 7954 outpatients, the prevalence of reflux esophagitis was 20.84%.
Patients with IgG-mediated food intolerance and metabolic syndrome are at higher risk of developing reflux esophagitis, while those with H. pylori infection are at lower risk. IgG-mediated FI reduces the risk of RE in patients with H. pylori infection, while metabolic syndrome increases the risk of RE in these patients.
In the management of RE, preventing the induction of IgG-mediated FI and optimal diagnosis and treatment of metabolic syndrome may reduce the occurrence of RE.